Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
With
Lawson Health Research Institute Internal Review Fund
University of Western Ontario, Canada
Age
40–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Men
Age of 40 years or greater
Diagnosis of advanced prostate cancer (ie: prostate-specific antigen \[PSA\] less than 25 ug/L and undergoing continued treatment with leuteinizing hormone-releasing hormone \[LHRH\] therapy)
Willing and able to consent
You may not be if
Metastatic disease to bone
Medications affecting bone turnover (bisphosphonate, steroids, anticonvulsant)
Renal failure (serum creatinine \> 200 umol/L)
Co-morbidity factors affecting bone density (ie: Paget's, rheumatoid arthritis)
Factors affecting ability to perform the bone density tests using femoral head measurements (ie: bilateral hip arthroplasty)
Cancer other than skin, except when, in the investigators' opinion, it is determined to be appropriate and not adversely affect the outcome of the trial
